Zinger Key Points
- The company will continue scaling its export of medicinal cannabis products to Germany, as well as enter the UK, Polish, and French markets.
- SafriCanna reconfirms plans to invest $40 million in its production expansion.
SafriCanna has received confirmation of its EU-GMP certification. This certification is required by producers of medicinal cannabis outside of the EU who wish to export to countries in the European Union.
According to the company it operates the largest cannabis production facility in South Africa. Situated at Centurion, Gauteng, the facility is located at an altitude of 1,500 meters, which is optimal for cannabis production. The company supplies its products, which contain high levels of THC, to wholesalers. SafriCanna currently employs more than 70 employees, and the company expects this number to grow to over 600 in line with expansion as it caters to increased European and global demand.
The company has also reconfirmed that it will invest $40 million on expanding its current facilities, with a view to increasing its production to 25,000 kilograms of cannabis flowers a year from 5,000 kilograms in the immediate term.
Bassim Haidar, founder of SafriCanna, stated: "EU-GMP Certification is a huge milestone for the company, and now puts us in prime position to become one of the world’s major producers of medicinal cannabis. EU-GMP Certification is validation of the quality, integrity, and robustness of our production processes and facility. It is also an endorsement in the quality of our growing, technical, and R&D teams. Europe is an immense and growing market, and we intend to become the producer-of-choice of medicinal cannabis within these countries.”
"Regulation, such as EU-GMP Certification, is a good thing for the industry. It ensures that standards are being upheld in the industry, and it will provide reassurance to patients that products are safe and of high quality. This certification will also cement South Africa’s position as one of the best places to grow cannabis worldwide. We are seeing a strong, innovative, and high-quality cannabis industry evolve in South Africa, and we will play our own role in supporting the growth of the sector locally with our own continued investment and expansion," concluded Haidar.
Photo: Courtesy of SafriCanna
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.